SCHEMBL30751445

SCHEMBL30751445

CC(C)(C)OC(=O)NCc1cc(F)cc(-c2cnsc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM2 Q14416 1/20 0.41
▸ DYRK1A Q13627 1/20 0.41
▸ NAMPT P43490 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ GLS O94925 2/20 0.36
▸ HDAC1 Q13547 2/20 0.35
▸ CA12 O43570 1/20 0.35
▸ CA1 P00915 1/20 0.35
▸ CA2 P00918 1/20 0.35
▸ CA9 Q16790 1/20 0.35
▸ KDM4A O75164 1/20 0.35
▸ JAK2 O60674 1/20 0.35
▸ JAK1 P23458 1/20 0.35
▸ CACNA1H O95180 1/20 0.35
▸ CACNA1B Q00975 1/20 0.35
▸ CACNA1C Q13936 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ BRD4 O60885 2/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35
▸ ADORA3 P0DMS8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27375434 1.00 GRM2 (0.41) GRM2DYRK1ANAMPTL3MBTL1GLS
SCHEMBL27375482 0.81 GRM2 (0.42) GRM2DYRK1ANAMPTL3MBTL1GLS
SCHEMBL30751360 0.81 GRM2 (0.42) GRM2DYRK1ANAMPTL3MBTL1GLS
SCHEMBL27375085 0.81 ROCK2 (0.49) GRM2DYRK1AL3MBTL1
SCHEMBL30751397 0.81 ROCK2 (0.49) GRM2DYRK1AL3MBTL1
SCHEMBL12791343 0.80 GRM2 (0.46) GRM2NAMPTL3MBTL1GLSHDAC1
SCHEMBL21994269 0.77 GRM2 (0.42) GRM2DYRK1ANAMPTL3MBTL1GLS
SCHEMBL30751378 0.76 GRM2 (0.42) GRM2DYRK1ANAMPTL3MBTL1GLS
SCHEMBL27375848 0.76 GRM2 (0.42) GRM2DYRK1ANAMPTL3MBTL1GLS
SCHEMBL30751448 0.75 GRM2 (0.43) GRM2DYRK1ANAMPTL3MBTL1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4567035-A1 NOVEL COMPOUND AS HYPOXIA-INDUCIBLE FACTOR 1(HIF-1) INHIBITOR OR VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Nextgen Bioscience Co., Ltd. (KR) 2025-06-11 — — EP disclosed
WO-2024030000-A1 NOVEL COMPOUND AS HYPOXIA-INDUCIBLE FACTOR 1(HIF-1) INHIBITOR OR VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 넥스트젠바이오사이언스 2024-02-08 — — WO disclosed
Send feedback